InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (12 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Keyes Jason A, Chief Financial Officer. Officer active across 3 companies, notably Equillium, Inc.. Cumulatively, 19 reports have been logged. Breakdown: 1 buy · 12 sells. Total volume traded: €239k. History available since 26 May 2021. The latest transaction was filed on 10 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Keyes Jason A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
700 shares@ US$16.00Common StockSEC:0001678152-26-000003:0
Canonical exit: 8 Nov 2026 (T+90)
10,000 shares@ US$0.651.4% of flowCommon StockSEC:0001415889-25-002070:0
15,000 shares@ US$0.541.7% of flowCommon StockSEC:0001415889-25-000843:0
10,000 shares@ US$0.701.5% of flowCommon StockSEC:0001415889-24-026987:0
10,000 shares@ US$0.811.6% of flowCommon StockSEC:0001415889-24-024079:0
10,000 shares@ US$0.871.8% of flowCommon StockSEC:0001415889-24-019776:0
15,000 shares@ US$0.561.8% of flowCommon StockSEC:0001209191-24-000515:0
4,444 shares@ US$1.191.1% of flowCommon StockSEC:0001209191-23-001367:0
7,000 shares@ US$2.834.5% of flowCommon StockSEC:0001209191-22-048037:0
40,000 shares0Common StockSEC:0001485003-22-000082:0
5,000 shares@ US$2.520.0086% mcap3.2% of flowCommon StockSEC:0001209191-22-034749:0
8,000 shares@ US$3.189.5% of flowCommon StockSEC:0001209191-22-023220:0
5,585 shares@ US$2.354.7% of flowCommon StockSEC:0001209191-21-069177:0
5,000 shares@ US$5.08039.2% of flowCommon StockSEC:0001209191-21-067752:0
8,000 shares@ US$6.740518.8% of flowCommon StockSEC:0001209191-21-058029:0
5,000 shares@ US$5.7179.9% of flowCommon StockSEC:0001209191-21-048405:0
5,535 shares@ US$2.354.4% of flowCommon stock, par value $0.0001 per shareSEC:0001209191-21-040314:0
5,000 shares@ US$6.49679.8% of flowCommon StockSEC:0001209191-21-036648:0
5,000 shares@ US$6.49679.8% of flowCommon StockSEC:0001209191-21-036674:0
19 of 19 declarations
About Keyes Jason A
Keyes Jason A is Chief Financial Officer and has filed 18 disclosures in total. In the 18 sampled filings, all transactions are sales, for a total of EUR 228824, between 2021-05-28 and 2025-01-24. He is linked to Equillium, Inc. as Chief Financial Officer and to Sesen Bio, Inc. as Director.
